• Discounts and special offers
  • Subscriber-only articles and interviews
  • Breaking news and trending topics

Already a subscriber?

By signing up, you accept Moneywise's Terms of Use, Subscription Agreement, and Privacy Policy.

Not interested ?

Economy
Founder of The Robin Hood Foundation, Paul Tudor Jones speaks on stage during The Robin Hood Foundation's 2018 benefit Kevin Mazur/Getty Images

Billionaire Paul Tudor Jones warns of America's ticking ‘debt bomb’ — CBO projections suggest US interest spending is on track to surpass defense and Medicare in 2024

The U.S. federal government’s rising debt is alarming to many, with legendary investor Paul Tudor Jones also expressing significant concern.

In a recent interview with CNBC, the billionaire and founder of Tudor Investment Corporation highlighted the looming threat of America's "debt bomb" potentially reaching a critical point.

Advertisement

Jones acknowledged the current strength of the U.S. economy but attributed it to the government's extensive borrowing and spending.

He cautioned about the repercussions of persistent deficit spending, stating, “We've got a 6%-7% budget deficit. We're fast-pouring consumption like crazy. It should be going gangbusters because we've got an economy on steroids, and it's unsustainable.”

The Commerce Department's advance estimate revealed that real GDP in the U.S. experienced a 3.3% annual growth rate in Q4 of 2023, surpassing the anticipated 2% increase set by economists.

The stock market has witnessed substantial growth, too, with the S&P 500 surging 28% over the past 12 months.

However, Jones warned that the burgeoning debt issue is bound to impact the market sooner or later, stating, “It could be this year, it could be next year. Productivity may mask and it might be three or four years from now but clearly, clearly we're on an unsustainable path."

Interest payments to surpass Medicare spending

The U.S. national debt has alarmingly exceeded $34 trillion, leading to significant interest payment obligations.

Advertisement

The Congressional Budget Office (CBO) reported a sharp increase in net interest payments on the debt over the years, escalating from $223 billion in fiscal year 2015 to $659 billion in fiscal year 2023.

For fiscal year 2024, the CBO projects that the U.S. government will spend $870 billion on net interest payments, surpassing expenditures on national defense ($822 billion) and Medicare ($851 billion). This would make net interest payments the second-largest budget item, trailing only behind Social Security, noted the Committee for a Responsible Federal Budget (CRFB)

The non-partisan think tank emphasized the need for "thoughtful deficit reduction" to mitigate interest costs and warned that without such action, debt will “represent a growing threat to our economy, our health care system, and our national security.”

In fiscal year 2023, which ended Sept. 30, 2023, the federal government spent $6.13 trillion and collected $4.44 trillion in revenue, resulting in a deficit of $1.7 trillion.

This pattern of deficit spending, where expenditures exceed revenue, has continued into fiscal year 2024. The federal budget deficit has already exceeded $531 billion as of Feb. 2024.

You May Also Like

Share this:
Jing Pan Investment Reporter

Jing is an investment reporter for MoneyWise. He is an avid advocate of investing for passive income. Despite the ups and downs he’s been through with the markets, Jing believes that you can generate a steadily increasing income stream by investing in high quality companies.

more from Jing Pan

Explore the latest

Disclaimer

The content provided on Moneywise is information to help users become financially literate. It is neither investment, tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities, enter into any loan, mortgage or insurance agreements or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter. Advertisers are not responsible for the content of this site, including any editorials or reviews that may appear on this site. For complete and current information on any advertiser product, please visit their website.

†Terms and Conditions apply.